Navigation Links
| 5/21/2013 | ALBANY, New York , May 21, 2013 According to a new market report published by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, Reagents, Drug Discovery, Life Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market... [Comments] |
| 5/21/2013 | Toronto, Canada (PRWEB) May 21, 2013 As the R&D sector becomes increasingly competitive, there is a strong push within the industry to deliver better products, faster. Collaborations between Contract Development and Manufacturing Organizations and pharma companies often means turning big ideas into reality, within short time frames. Microtablets, developed in collaboration with Sensi... [Comments] |
| 5/21/2013 | Miami, FL (PRWEB) May 21, 2013 Many have long discussed the link between mental stress and breakouts as contributor to acne. Recently physicians from Clinical Psychiatry.com readdressed the topic of the effects of mental stress on the skin, and suggested using hypnotherapy and other mental health treatments to help reduce the chemicals produced from stress that cause acne. Doctors in... [Comments] |
Emerson Resources Announces CEO Retirement and Appointment of Successor
| 5/21/2013 | Norristown, PA (PRWEB) May 21, 2013 Emerson Resources Inc. , a premier pharmaceutical development company, today announced that Dr. Charles Signorino, the Company’s Chief Executive Officer and Chairman of the Board, retired on April 1, 2013 after 32 years of service. As part of Emerson Resources’ planned leadership succession process, Adolfo Gomez, Emerson’s current President, has been nam... [Comments] |
| 5/21/2013 | ROCKVILLE, Md. , May 21, 2013 MacroGenics, Inc. today announced that an abstract titled, "Phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), in patients with advanced solid tumors expressing the HER2 oncoprotein," will be presented at the 2013 Annual Meeting of the American Society of Clinical Oncology during the Developmental Thera... [Comments] |
Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference
| 5/21/2013 | ROCKVILLE, Md. , May 21, 2013 Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, announced today that Jeffrey Riley , CEO, will present at the 2 nd Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 in New York City at the Grand Hyatt Hotel. Mr. Riley is scheduled... [Comments] |
| 5/21/2013 | BALTIMORE , May 21, 2013 Personal Genome Diagnostics Inc. (PGDx), today announced that it will use its proprietary methodologies and expertise in genomic analysis of defined cancer subtypes to identify novel kinase targets in collaboration with Blueprint Medicines. PGDx is an innovator in conducting patient-specific analyses aimed at identifying genomic alterations... [Comments] |
| 5/21/2013 | New York, NY (PRWEB) May 21, 2013 Bed bugs have become so widespread in the past few years. And according to My Cleaning Products, many turn to chemical-based pesticides for help to completely get rid of them. However, because of the health and environmental risks those solutions present, the company advised the public to kill bed bugs with Bed Bug Bully instead. According to My Clean... [Comments] |
Revolutionary Science Announces New Automatic and Manual Colony Counting Products
| 5/21/2013 | Minneapolis, MN (PRWEB) May 21, 2013 Revolutionary Science, the manufacturer of the IncuCount , a patented automatic colony counter, announced today that they have expanded their colony counter product line to include four products , the IncuCount, IntelliCount, InCount and ImpressCount. These affordable colony counters that range in price and sophistication are especially useful in food... [Comments] |
| 5/21/2013 | (PRWEB) May 21, 2013 NANONEX CORPORATION, a pioneer and leading company in nanoimprint solutions , today announced the successful delivery and installation of a new nanoimprint lithography (NIL) manufacturing system, the NX-M200B, to a major Japanese manufacturing company. Nanonex’s NX-M200B is a fully-automated, production-ready, advanced nanoimprint lithography tool that has the ab... [Comments] |
(Date:5/21/2013)... of all types become most deadly when they metastasize ... reached this stage, it becomes very difficult for doctors ... develop. Now, researchers at the University of Missouri have ... lymphoma tumor cells wherever they may be in the ... the MU College of Veterinary Medicine, says being able ...
(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
(Date:5/21/2013)... genes function without changing the underlying DNA sequence, ... pregnant women during any trimester, potentially providing a ... after giving birth, and an opportunity to intervene ... the small study involving 52 pregnant women are ... . , "Postpartum depression can be harmful to ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3... small biotech company in Boulder, CO, announced today that they ... The FluChip was invented by a joint team of ... Disease Control and Prevention in an NIH sponsored effort led ... CEO of InDevR, said that InDevR has arranged to test ...
... grants totaling $24 million in U.S. dollars have ... hospitals to fund studies related to asthma and ... cancer. The extramural grants were awarded by ... for Science, Technology and Research), the government agency ...
... The Entomological Society of America (ESA) will feature ... Meeting in Indianapolis, December 13-16, 2009. Integrative ... Cold Case Files: Integrative Perspectives on Physiological ... Evolutionary Arms Race of Resistance in Herbivores ...
Cached Biology News:FluChip technology licensed to combat deadly flu virus 2Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 2Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 3Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 4Symposia selected for Entomological Society of America meeting 2Symposia selected for Entomological Society of America meeting 3Symposia selected for Entomological Society of America meeting 4... Magnetofection technology, SilenceMag is the most ... rapid and easy to use, SilenceMag ... Specifically designed for siRNA delivery, SilenceMag ... low doses of siRNA.,SilenceMag formulation gives ...
... Last innovation from Magnetofection technology, SilenceMag ... system available. Simple, rapid and easy ... and non toxic. Specifically designed for ... silencing at very low doses of ...
... 4 H 10 O 2 S ... SPECIFICATIONS Form: White crystalline powder Assay: ... Identity: By IR Melting Point: greater ... DTT: less than or equal to ...
... Software reads and processes raw ... microarray data for analysis. ... one 2-year license for Feature ... , * one CD-ROM ...
Biology Products:(Date:5/21/2013)... of a new study led by George Washington ... that nucleation of ice in small droplets is ... behavior at the nanoscale. The formation of ice ... research question whose answer also has important implications ... The crystallization of ice from supercooled water is ...
(Date:5/21/2013)... , May 21, 2013 The ... and Transplant Association) is the biggest congress in ... therapy. Nearly 10,000 participants are in Istanbul ... latest research findings. New pioneering studies have been presented: ... FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE" ...
(Date:5/21/2013)... 21, 2013 Clinverse, Inc. ... for clinical trials, announced today it has formed ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates ... SpendMD ™, Aggregate Spend Solutions’ recently-launched ... tracking and reporting transfer of value at investigator ...
(Date:5/21/2013)... ALBANY, New York , May 21, 2013 /PRNewswire/ ... published by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip ... Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, ... USD 2.4 billion in 2011 and is expected to ... 2018, to reach an estimated value of USD 4.7 ...
Breaking Biology Technology:Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5[0] Study led by GW professor provides better understanding of water's freezing behavior at nanoscale[0] ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials[0] Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC[0] The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research
... China, May 14 Simcere Pharmaceutical,Group (NYSE: SCR ), ... of the patented anti-cancer biotech,product Endu in China, today announced ... conferences:, * Brean Murray Carret & Co. ... Waldorf-Astoria in New York on Monday, May 19, 2008 at ...
... 14 SynCo Bio Partners B.V., a leading,GMP ... manufacture and release of ActoGeniX, drug substance AG011 ... ulcerative colitis patients., ActoGeniX is focused on ... of protein-based biopharmaceuticals that can,be orally administered. The ...
... CITY, New Jersey, May 14, Rosetta Genomics (Nasdaq: ... results on May 21, 2008, before the,U.S. markets open. ... webcast to discuss these results at 4:30 p.m. ET ... call, U.S. and Canadian participants may,dial +1-866-966-5335; international participants ...
Cached Biology Technology:Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York 2SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials 2SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials 3Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results 2| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |